InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (6 ops.)
Insider track record
OtherDisclosed buys
1
Disclosed sells
6
T+90 hit rate
60%
T+90 mean return
+36.6%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Edwards Larry Todd, See Remarks. Insider active across 1 company, notably Arcutis Biotherapeutics, Inc.. In total, 11 reports have been recorded. Breakdown: 1 buy · 6 sells. Total volume traded: €942k. Activity tracked since 27 September 2023. The latest transaction was filed on 6 November 2025 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations11 total
29,131 shares@ US$25.159767.7% of flowCommon StockSEC:0001994805-25-000008:0
4,207 shares@ US$19.988550.0% of flowCommon StockSEC:0001994805-25-000005
4,207 shares@ US$19.98850.0027% mcap50.0% of flowCommon StockSEC:0001994805-25-000005:0
7,451 shares@ US$14.07199.9% of flowCommon StockSEC:0002065881-25-000009:0
38,000 shares0Common StockSEC:0001787306-25-000039:0
2,173 shares@ US$12.702.9% of flowCommon StockSEC:0001787306-25-000013:0
1,093 shares@ US$7.1060.8% of flowCommon StockSEC:0001787306-24-000169:0
Ideal exit: 27 Aug 2025 (T+270)
▼
3,725 shares@ US$10.01223.6% of flowCommon StockSEC:0001787306-24-000136:0
60,000 shares0Common StockSEC:0001787306-24-000081:0
28,000 shares0Common StockSEC:0001787306-24-000010:0
60,000 shares0Common StockSEC:0001787306-23-000113:0
11 of 11 declarations
About Edwards Larry Todd
Larry Todd Edwards is associated with Arcutis Biotherapeutics, Inc. His exact role is not specified, but he is involved in strategic activities within the company. His expertise contributes to Arcutis' direction.
